Does Sarepta Therapeutics Inc (NASDAQ:SRPT) presents a BIG investment opportunity?
Stocks of Sarepta Therapeutics Inc (NASDAQ:SRPT) traded higher last session on Wall Street, up 13.68% to $76.52. According to the data, Sarepta Therapeutics Inc (NASDAQ:SRPT) has 19 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $220.00 and […]
Sarepta Therapeutics Inc. (NASDAQ:SRPT): A Fundamentally Weighted Stock for Long-Term Investors
The stock of Sarepta Therapeutics Inc. (NASDAQ:SRPT) last traded at $107.35, up 2.05% from the previous session. Data from the available sources indicates that Sarepta Therapeutics Inc. (NASDAQ:SRPT) is covered by 20 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of […]
